Here’s what happened on Friday: India’s drug regulator has granted emergency use authorisation to ZyCov-D, a three-dose coronavirus vacci...
Here’s what happened on Friday:
- India’s drug regulator has granted emergency use authorisation to ZyCov-D, a three-dose coronavirus vaccine, developed by pharmaceutical company Zydus Cadila, said the Union Ministry of Science and Technology on Friday. This is the first vaccine in the country that can be administered to children aged 12 years and above.
- India on Friday recorded 36,571 new coronavirus cases, taking the tally to 3,23,58,829 since the pandemic broke out in January last year. The number of cases was 0.46% higher than Thursday’s count of 36,401 infections. The country’s toll rose to 4,33,589 with 540 new deaths, while the number of active cases declined by 524 to 3,63,605.
- Johnson and Johnson has applied to India’s drug regulator to conduct trials of its Covid-19 vaccine among children in the 12-17 age group, a statement from the pharmaceutical company said.
- The Delta variant of Covid-19 may mostly be responsible for breakthrough infections in India, the Indian Sars-CoV-2 Genomics Consortium, or INSACOG, a scientific advisory group that coordinates the country’s genome sequencing work, said.
- The Delhi government has notified a policy to make the national Capital “self-reliant” in production of medical oxygen to tackle any possible Covid-19 crisis in future, PTI reported, citing officials. The Medical Oxygen Production Promotion Policy of Delhi 2021 was approved by the Delhi...
